CCL3 and Alzheimer disease: The analysis of a panel of cytokines, chemokines, and growth factors (Table 3) revealed a statistically significant increase of circulating levels of VEGF, IL-15, IP-10, GM-CSF, IL-6 and MIP-1α in TET-AD patients compared to TET patients (Figure 3).